Paolo Uva is a researcher in the Bioinformatics group of CRS4. He obtained his Laurea (MSc) degree in Biology in 1999 from the University La Sapienza in Rome, Italy and then he moved in France where he received in 2002 a PhD degree in molecular phylogeny from the University of Tours, France. In 2004 he obtained a Master in Bioinformatics at the University of Geneva/Lausanne, Switzerland. As a postdoctoral scientist, he worked at the University La Sapienza in Rome, Italy (2004-2005) on the analysis of genome-wide expression data before joining in 2006 the Istituto di Ricerche di Biologia Molecolare (IRBM, owned by Merck & Co. Inc), Rome where he focused on microarray design, identification of molecular signatures in cancer and development of molecular biomarkers. In 2009 he moved to CRS4. His research interests include the use of molecular signatures as biomarkers (predictors of prognosis, drug resistance), epigenomics, study of non coding RNAs. His research is published in international refereed journals and conferences and he has served as reviewer in the area of functional genomics.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.